29 related articles for article (PubMed ID: 10344471)
1. Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD.
Cazzola M; Page CP; Wedzicha JA; Celli BR; Anzueto A; Matera MG
Respir Res; 2023 Jul; 24(1):194. PubMed ID: 37517999
[TBL] [Abstract][Full Text] [Related]
2. Reactive Sulfur Compounds in the Fight against COVID-19.
Iciek M; Bilska-Wilkosz A; Kozdrowicki M; Górny M
Antioxidants (Basel); 2022 May; 11(6):. PubMed ID: 35739949
[TBL] [Abstract][Full Text] [Related]
3. Understanding the Role of the Antioxidant Drug Erdosteine and Its Active Metabolite on
Cattò C; Villa F; Cappitelli F
Antioxidants (Basel); 2021 Nov; 10(12):. PubMed ID: 34943025
[TBL] [Abstract][Full Text] [Related]
4. Respiratory Cilia as a Therapeutic Target of Phosphodiesterase Inhibitors.
Joskova M; Mokry J; Franova S
Front Pharmacol; 2020; 11():609. PubMed ID: 32435198
[TBL] [Abstract][Full Text] [Related]
5. Mucoactive and antioxidant medicines for COPD: consensus of a group of Chinese pulmonary physicians.
Yan X; Song Y; Shen C; Xu W; Chen L; Zhang J; Liu H; Huang M; Lai G; Qian G; Wang J; Ye X; Zheng J; Bai C
Int J Chron Obstruct Pulmon Dis; 2017; 12():803-812. PubMed ID: 28405161
[TBL] [Abstract][Full Text] [Related]
6. Is intratympanic injection of erdosteine protective against cisplatin-induced ototoxicity?
Saliba I; El Fata F
Neurotox Res; 2012 Apr; 21(3):302-8. PubMed ID: 21989624
[TBL] [Abstract][Full Text] [Related]
7. Renoprotective effect of erdosteine in rats against gentamicin nephrotoxicity: a comparison of 99mTc-DMSA uptake with biochemical studies.
Cabuk M; Gurel A; Sen F; Demircan N
Mol Cell Biochem; 2008 Jan; 308(1-2):35-42. PubMed ID: 17899318
[TBL] [Abstract][Full Text] [Related]
8. The protective effect of erdosteine against ototoxicity induced by cisplatin in rats.
Kalcioglu MT; Kizilay A; Gulec M; Karatas E; Iraz M; Akyol O; Egri M; Ozturan O
Eur Arch Otorhinolaryngol; 2005 Oct; 262(10):856-63. PubMed ID: 15742177
[TBL] [Abstract][Full Text] [Related]
9. Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent.
Cazzola M; Page C; Rogliani P; Calzetta L; Matera MG
Drugs; 2020 Nov; 80(17):1799-1809. PubMed ID: 33025535
[TBL] [Abstract][Full Text] [Related]
10. Erdosteine: antitussive and anti-inflammatory effects.
Dal Negro RW
Lung; 2008; 186 Suppl 1():S70-3. PubMed ID: 18185958
[TBL] [Abstract][Full Text] [Related]
11. The effect of erdosteine and its active metabolite on reactive oxygen species production by inflammatory cells.
Miyake K; Kaise T; Hosoe H; Akuta K; Manabe H; Ohmori K
Inflamm Res; 1999 Apr; 48(4):205-9. PubMed ID: 10344471
[TBL] [Abstract][Full Text] [Related]
12. Effects on the reactive oxygen species of erdosteine and its metabolite in vitro.
Hosoe H; Kaise T; Ohmori K
Arzneimittelforschung; 2002; 52(6):435-40. PubMed ID: 12109043
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of metabolite I of erdosteine on the generation of nitric oxide and peroxynitrite chemiluminescence by human neutrophils.
Dal Sasso M; Culici M; Bianchi T; Fonti E; Braga PC
Pharmacology; 2004 Jul; 71(3):120-7. PubMed ID: 15161993
[TBL] [Abstract][Full Text] [Related]
14. The SH-metabolite I of erdosteine, a mucolytic drug, enhances the inhibitory effect of salbutamol on the respiratory burst of neutrophils.
Dal Sasso M; Bovio C; Culici M; Fonti E; Braga PC
Drugs Exp Clin Res; 2002; 28(4):147-54. PubMed ID: 12512232
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
